Argenx
ARGX
#535
Rank
C$50.96 B
Marketcap
$816.15
Share price
-2.94%
Change (1 day)
59.33%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$5.59

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.78. In 2022 the company made an earnings per share (EPS) of -$18.22.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.59-69.32%
2022-$18.22